Dose Adjusted vs. Fixed Dose Unilateral Laparoscopic Ovarian Drilling in PCOS Patients
Launched by HATEM ABUHASHIM · Jul 13, 2019
Trial Information
Current as of May 12, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of PCOS will be based on the revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS and its modification (ESHRE, 2018).
- • CCR will be considered if persistent anovulation with 150 mg CC daily for 5 days per cycle, for at least three cycles.
- • Only patients with a phenotype characterized by oligomenorrhoea/anovulation, hyperandrogenaemia and polycystic ovaries on ultrasound examination (PCOM) and a phenotype characterized by oligomenorrhoea/anovulation and PCOM will be enrolled in the study.
- • Age: 20-34 years.
- • Body mass index \< 30 kg/m2
- • Patent fallopian tubes by hysterosalpingography.
- • Normal semen analysis of husbands.
- Exclusion Criteria:
- • Age ≥ 35 years.
- • BMI ≥ 30
- • Previous history of LOD
- • PCOS phenotypes with regular menses or without PCOM ovaries on USS.
- • Other causes of infertility
- • Women with adrenal hyperplasia, thyroid disease, Cushing's syndrome, hyperprolactinemia and a tumor-related excess of androgen.
About Hatem Abuhashim
Hatem Abuhashim is a dedicated clinical trial sponsor with a focus on advancing medical research and improving patient outcomes. With a commitment to ethical practices and rigorous scientific standards, he leads initiatives that explore innovative therapies and treatment modalities across various therapeutic areas. Leveraging a robust network of healthcare professionals and research institutions, Hatem Abuhashim ensures the successful execution of clinical trials, fostering collaboration and transparency while prioritizing participant safety and data integrity. His expertise and leadership in the field contribute significantly to the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Hatem Abu Hashim, MD. FRCOG. PhD
Study Chair
Faculty of Medicine, Mansoura University
Eman Lotfy, MBBCh
Principal Investigator
New Mansoura General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials